Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Citation: Boominathan, Therapeutic insights into the treatment of hypertension, endothelial dysfunction and cardiovascular diseases: MCP-1 promotes endothelium-dependent vasorelaxation via up regulation of its target gene, 2/November/2014, 10.35 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests that MCP-1, by decreasing the expression of its target gene, it may rescue pulmonary arterial hypertension. Thus, pharmacological formulations encompassing “MCP-1 activators“ may be used to treat pulmonary arterial hypertension.
Amount: $300
Undisclosed information: A mechanistic insight into how MCP-1 rescues pulmonary arterial hypertension.
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Web: http://genomediscovery.org